Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Bullboard Posts
Post by LEOTHELIONon May 12, 2017 11:39pm
186 Views
Post# 26240129

Any Lab Test Now (ALTN)

Any Lab Test Now (ALTN)GEN has found a different way to have it's tests become available to patients. By visiting any one of the 165 ALTN locations across the US, a person can select whatever lab test they want. This is a different model from someone going into a doctor's office and having a physician promote/order a particular screening test. I like the idea that GEN has found another way to get its tests on the menu. When visiting ALTN's website, you can click on any test and find out about its characteristics and cost. According to yesterday's press release, will we see Breastsentry, Colonsentry, etc. on the menu by the end of May? ("GeneNews said that it expects ALTN partnership activities to begin before the end of this month"). So come on Mr. Tripp, here is an easy example of where you have made a promise or prediction pertaining to a timeline. Give the investors some confidence by providing an update at the end of May about ALTN partnership "activities". And while you are at it, let's get some more health groups signed up!
Bullboard Posts